04 Mar The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study
Posted at 10:26h
in COVID-19
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" css=".vc_custom_1584737067410{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}" z_index=""][vc_column css=".vc_custom_1584737077948{margin-top: 0px !important;}"][vc_column_text css=".vc_custom_1614845763609{margin-top: 0px !important;padding-top: 0px !important;}"]Gregoriano C, Koch D, Kutz A, Haubitz S, Conen A, Bernasconi L, et al. [/vc_column_text][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no"...